Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Abadi Lestari Indonesia Tbk. (RLCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Abadi Lestari Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Abadi Lestari Indonesia Tbk. trades at Rp4,500 (market cap 14.25T, 449.7K 24h volume). The key difference: Abadi Lestari Indonesia Tbk. is far larger — about 85.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Abadi Lestari Indonesia Tbk. is more actively traded (449.7K versus 324K). Which is the better fit depends on your goals.
| OBAT | RLCO | |
|---|---|---|
Market Cap | 166.01B | 14.25T |
Volume | 324K | 449.7K |
Lot | 3.24K | 4.5K |
Turnover | 77.68M | 2B |
Average Price | 239.75 | 4,442.22 |
Value | 77.68M | 2B |
Indicative Equilibrium Price | 240 | 4,500 |
Indicative Equilibrium Volume | 1 | 23 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Abadi Lestari Indonesia Tbk.
PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →
